#betav

[sonhaberim]

Vali Ustaoğlu, Betav İle Bir Araya Geldi

Vali Ustaoğlu, Betav İle Bir Araya Geldi Son Haber

BİTLİS EĞİTİM VE TANITIM VAKFI (BETAV) BAŞKANI MUZAFFER AHLAT VE YÖNETİM KURULU ÜYELERİ, VALİ İSMAİL USTAOĞLU İLE DEĞİRMENDERE KIR BAHÇESİNDE BİR ARAYA GELDİ.

Vali Ustaoğlu, Betav İle Bir Araya Geldi Son Haber

Devamını Gör http://ift.tt/2tOfbjB via SonHaber.im http://ift.tt/eA8V8J

[dbabble]

BETAV Virus

Virology Dept.   ZETA Base No. 004 Serial #970-71-476632 Sector 9 ZERO B6 // CLASSIFIED REPORT:

Supervisor:

Dr. Johan K. Maynard ID # 601-301M

Co-Supervisor:

Srgt Hiroki Miyamoto ID # 398-406S

Date Filed:

2/17/2021

NOTE: Listed information concerns an on-going biotechnological project; information is VOID upon bulletin unless confirmed by the overseeing scientist or replaced by updated information. Data listed does not include hypotheses and are all based upon conducted experiments and/or combat deployment.

 Name: 

Beta ZERO (Beta V.)

Initial Classification:

negative-sense single-stranded RNA Bacteriophage

Host Bacteria:

Staphylococcus aureus (pH 4-9)

Molecular Structure: 

(N/A)

Capsid:

icosahedrons

Purpose:

Anti-personnel viral contagion

Pathogenesis: 

transmissible spongiform encephalopathy (genus: Homo Sapiens), Blindness, Epilepsy, Mutation, Others Currently Unknown.

Sub Classification:

Capable of producing retroviridae and other particle viroids upon successful replication within host cell; secondary mutation promotes increased RNA polymerase within 15 hour time frame, converting negative-sense to positive-sense, activating the viron. Further mutation may produce ambisence viroids capable of translating both senses, further improving virility.

Secondary Observation:

N/A

Field Observation:

N/A – Prototype Virus, real time testing unauthorized.

REPORT:

Supervisor:

Dr. Johan K. Maynard ID # 601-301M

Co-Supervisor:

Col.  Bami Faloeu ID # 003-115S

Date Filed:

7/8/2022

NOTE: Listed information concerns an on-going biotechnological project; information is VOID upon bulletin unless confirmed by the overseeing scientist or replaced by updated information. Data listed does not include hypotheses and are all based upon conducted experiments and/or combat deployment.

UPDATE: Subject No 000, named ZERO. Power buffer failure at 10% maximum capacity 07:21:00 Hours; fatal core error resulted in destruction of Sector 9 within Scientific branch. Subject ZERO still missing, presumed to be at large and within the vicinity. ADMINISTRATIVE  NOTE: Supervisor Dr.Johan K. Maynard has contracted the BETAV virus since starting the report and will be replaced by Dr. Sayuri Tanaka.

NOTE:  All scientists in employment at Sector 9 must comply with a mandatory health examination and screening for BETAV. Quarantine must be observed for at least 48hours after initial inspection. Any sign of possible infection will result in an extended quarantine of up to 6 months. Contact with non-staff is strictly prohibited before and during examination process; violators will be dealt with on individual basis and circumstance. 

CASUALTY REPORT

Science Branch Fatalities: 81 Science Branch Missing: 28 Science Branch Infected: 6 Science Branch Uninfected: 12

ZETA Sector 9 Fatalities: 106 ZETA Sector 9 Missing: 2 ZETA Sector 9  Infected: 0 ZETA Sector 9  Uninfected: 0

Name: 

Beta ZERO (Beta V.) , Publicly dubbed “BETAV”

Initial Classification:

negative-sense single-stranded RNA Bacteriophage

Host Bacteria/Cell: 

Staphylococcus aureus (pH4-9), Neurons, Glial

Capsid:

icosahedrons

Purpose:

Anti-personnel viral contagion

Pathogenesis: 

Transmissible Spongiform Encephalopathies (genus: Homo Sapiens), Blindness, Epilepsy, Acute Physical Mutation, Cerebral Hemorrhaging, Memory Loss, Retardation, Organ Failure, Hallucination, Panic Attacks, Others Unkown.

Sub Classification:

Capable of producing retroviridae and other particle viroids upon successful replication within host cell; secondary mutation promotes increased RNA polymerase within 15 hour time frame, converting negative-sense to positive-sense, activating the viron. Further mutation may produce ambisence viroids capable of translating both senses, further improving virility.

Secondary Observation:

Rate of mutation much higher than forecasted ; uncontrollable genetic variety and duplication. Replication success sufficient to upkeep with unsuccessful RNA duplication and transcribing – high rate or rejection by host cell, often fatal. Victims with exposure to source viroid showed only mild flu symptoms – secondary exposure from primary contractants resulted in death within 24 hours after the engineered RNA polymerase production after 15 hour window period. Primary victims highly contagious even after the subsiding of symptoms.   Note: Unusual mutations found within roughly 1% of subjects collected within the last 16 hours – strains named “Alpha” and “Omega”.

Alpha Betav Strain: Excessive physical mutation – mutations proved not only superficial but sub-epidermal changes as well. Organs and other bodily systems transfigured into an unknown genus – high amount of mental activity, roughly 200x that of a human. Different subject each displayed different characteristics, though classifiable into 3 distinct forms. Further research needed.

Omega Betav Strain: Unlike the Alpha strain, close to zero physical mutation ; brain activity close to 100% as opposed to the 10% of an uninfected human. One subject has displayed psychokinetic abilities; further research needed.

Field Observation:

N/A – Prototype Virus, real time testing unauthorized unless subject has already been exposed to the BETAV virus beforehand. Report all sightings of Alpha or Omega BETAV strains straight to Sections Manager and Head Scientist.